L-asparagine — Drug Target
All drugs that target L-asparagine — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Asparagine-specific Enzyme [EPC]
Marketed (3)
- Elspar · Merck & Co. · Asparagine-specific Enzyme [EPC] · Oncology
RYLAZE kills leukemic cells by depleting plasma asparagine, which they need for survival. - ASPARAGINASE ERWINIA CHRYSANTHEMI · Asparagine-specific Enzyme [EPC]
RYLAZE kills leukemic cells by depleting plasma asparagine, which they need for survival. - Asparlas · Pfizer · Asparagine-specific Enzyme [EPC] · Oncology
Calaspargase is an L-asparaginase enzyme that catalyzes the conversion of L-asparagine into aspartic acid and ammonia, leading to the depletion of plasma asparagine and the death of leukemic cells.